Inhibin B as a serum marker of spermatogenesis: Correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4059-4063

  Jensen, Tina Kold ^a   Andersson, Anna Maria ^a   Hjollund, Niels Henrik I ^b   Scheike, Thomas ^c   Kolstad, Henrik ^b   Giwercman, Aleksander ^a   Henriksen, Tine Brink ^d   Ernst, Erik ^d   Bonde, Jens Peter ^b   Olsen, Jørn ^e   Mcneilly, Allan ^f   Groome, Nigel P ^g   Skakkebæk, Niels E ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF AARHUS   (Denmark)

^f MEDICAL RESEARCH COUNCIL   (United Kingdom)

^g OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FOLLITROPIN; INHIBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; FOLLITROPIN BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; SPERMATOGENESIS; SPERMATOZOON COUNT;

EID: 9844238148     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.12.4059     Document Type: Article

References (24)

1. Carlsen E, Giwercman A, Keiding N, Skakkebæk NE. 1992 Evidence for decreasing quality of semen during past 50 years. Br Med J. 305:609-613.
2. Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. 1996 Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. Br Med J. 312:467-471.
3. Auger J, Kunstmann JM, Czyglik F, Jouannet P. 1995 Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 332:281-285.
4. Illingworth PJ, Groome NP, Bryd W, et al. 1996 Inhibin-B: a likely candidate for the physiologically important form of inhibin in man. J Clin Endocrinol Metab. 81:1321-1325.
5. Anawalt BD, Bebb RA, Matsumoto AM, et al. 1996 Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 81:3341-3345.
6. Krause W, Pflüger KH. 1989 Treatment with the gonadotropin-releasing hormone agonist burselin to protect spermatogenesis against cytotoxic treatment in young men. Andrologia. 21:265-270.
7. World Health Organization. 1992 WHO laboratory manual for the examination of human semen, and sperm-cervical mucus interaction. 3rd ed. Cambridge: Cambridge University Press.
8. Groome NP, Illingworth PJ, O'Brien M, et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1401-1405.
9. Heuchel V, Schwartz D, Price W. 1981 Within-subject variability and the importance of abstinence period for sperm count, semen volume and pre-freeze and post-thaw motility. Andrologia. 13:479-485.
10. Poland ML, Moghissi KS, Giblin PT, Ager JW, Olson JM. 1985 Variation of semen measures within normal men. Fertil Steril. 44:396-400.
11. Mallidis C, Howard EJ, Baker HWG. 1991 Variation of semen quality in normal men. Int J Androl. 14:99-107.
12. Faiman C, Winter JSD. 1971 Diurnal cycles in plasma FSH, testosterone and cortisol in men. J Clin Endocrinol Metab. 33:186-192.
13. Bremner WJ, Vitiello MV, Prinz PN. 1983 Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 56:1278-1281.
14. Winters SJ. 1991 Diurnal rhythm of testosterone and luteinizing hormone in hypogonadal men. J Androl. 12:185-190.
15. Krieger DT, Ossowski R, Fogel M, Allen W. 1972 Lack of circadian periodicity of human serum FSH and LH levels. J Clin Endocrinol Metab. 35:619-623.
16. Spratt DI, O'Dea LSL, Schoenfeld D, Butler J, Narasimha R, Crowley WF. 1988 Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol. 254:E658-E666.
17. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. 1990 Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab. 71:1616-1623.
18. Brennemann W, Sommer L, Stoffel-Wagner B, Bidlingmaier F, Klingmüller D. 1994 Secretion pattern of immunoreactive inhibin in men. Eur J Endocrinol. 131:273-279.
19. De Kretser DM, McFarlane JR. 1996 Inhibin in the male. J Androl. 17:179-182.
20. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley Jr WF. 1990 Immunoreactive inhibin alpha-subunit in human serum: implications for radio-immunoassay. J Clin Endocrinol Metab. 70:1208-1212.
21. Robertson D, Burger HG, Sullivan J, et al. 1996 Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab. 81:669-676. 6
22. Robertson DM, Sullivan J, Watson M, Cahir N. 1995 Inhibin forms in human plasma. J Endocrinol. 144:261-269.
23. De Kretser DM, McLachlan R, Robertson D, Burger HG. 1989 Serum inhibin levels in normal men and men with testicular disorders. J Endocrinol. 120:517-523.
24. Plymate SR, Paulsen CA, McLachlan RI. 1992 Relationship of serum inhibin levels to serum follicle stimulating hormone and sperm production in normal men and men with varicoceles. J Clin Endocrinol Metab. 74:859-864.